Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Nature Biomedical Engineering
|
April 6, 2019
A designer chaperone against prion diseases
Emiliano Biasini
Proteins
|
February 13, 2023
Functional, pathogenic, and pharmacological roles of protein folding intermediates
Emiliano Biasini, Pietro Faccioli
Sub-Cellular Biochemistry
|
September 26, 2025
Therapeutic Trajectories in Human Prion Diseases
Maria Letizia Barreca, Emiliano Biasini
Biological Chemistry
|
June 10, 2016
Common therapeutic strategies for prion and Alzheimer's diseases
Saioa R Elezgarai, Emiliano Biasini
Future Medicinal Chemistry
|
August 29, 2012
Targeting the cellular prion protein to treat neurodegeneration
Emiliano Biasini, David A Harris
Progress in Molecular Biology and Translational Science
|
September 22, 2020
Understanding prion structure and conversion
Giovanni Spagnolli, Jesús R Requena, Emiliano Biasini
Methods (San Diego, Calif.)
|
December 1, 2010
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guide
Tania Massignan, Emiliano Biasini, David A Harris
Prion
|
March 29, 2012
Ion channels induced by the prion protein: mediators of neurotoxicity
Isaac H Solomon, Emiliano Biasini, David A Harris
ACS Medicinal Chemistry Letters
|
November 19, 2020
The Compelling Demand for an Effective PrP<sup>C</sup>-Directed Therapy against Prion Diseases
Andrea Astolfi, Giovanni Spagnolli, Emiliano Biasini, et al.
Virus Research
|
December 3, 2014
Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases
Nunzio Iraci, Claudia Stincardini, Maria Letizia Barreca, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Nature Biomedical Engineering
|
April 6, 2019
A designer chaperone against prion diseases
Emiliano Biasini
Proteins
|
February 13, 2023
Functional, pathogenic, and pharmacological roles of protein folding intermediates
Emiliano Biasini, Pietro Faccioli
Sub-Cellular Biochemistry
|
September 26, 2025
Therapeutic Trajectories in Human Prion Diseases
Maria Letizia Barreca, Emiliano Biasini
Biological Chemistry
|
June 10, 2016
Common therapeutic strategies for prion and Alzheimer's diseases
Saioa R Elezgarai, Emiliano Biasini
Future Medicinal Chemistry
|
August 29, 2012
Targeting the cellular prion protein to treat neurodegeneration
Emiliano Biasini, David A Harris
Progress in Molecular Biology and Translational Science
|
September 22, 2020
Understanding prion structure and conversion
Giovanni Spagnolli, Jesús R Requena, Emiliano Biasini
Methods (San Diego, Calif.)
|
December 1, 2010
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guide
Tania Massignan, Emiliano Biasini, David A Harris
Prion
|
March 29, 2012
Ion channels induced by the prion protein: mediators of neurotoxicity
Isaac H Solomon, Emiliano Biasini, David A Harris
ACS Medicinal Chemistry Letters
|
November 19, 2020
The Compelling Demand for an Effective PrP<sup>C</sup>-Directed Therapy against Prion Diseases
Andrea Astolfi, Giovanni Spagnolli, Emiliano Biasini, et al.
Virus Research
|
December 3, 2014
Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases
Nunzio Iraci, Claudia Stincardini, Maria Letizia Barreca, et al.
Page
of 7